Med-tech companies raised a total of $25.37 billion in financings in 2024, up from $17.68 billion in 2023, though still significantly lower than previous years. The highest year for med-tech ...

The Biosecure Act may have died with the 118th U.S. Congress, but efforts to stop U.S. government funding of R&D in China are alive and well. Rep. Claudia Tenney, R-N.Y., introduced the Stop Funding ...

From Feb. 10, the U.S. NIH is to cut the amount of its grants that go to indirect costs, in a move it says will save $4 billion per annum, but which scientists say will hit breakthrough biomedical ...

A 1,000-person study using Heartflow Inc. technology demonstrated that findings of coronary plaque on heart CT scans could indicate which patients were at risk of cardiovascular events up to seven ...

A large-scale study cross-referencing genomic data from multiple sources with primary care health records has identified genetic overlaps in 72 chronic diseases, opening the way for a more holistic ...

In the early days of the second Trump administration, what will happen to various government science agencies is not yet ...

Leukemic stem cells (LSCs) and stemness signatures contribute to minimal residual disease in patients with acute myeloid ...

Biopharma companies secured $5.91 billion across 93 transactions in January 2025, a continuing upward swing from $4.69 ...

New gapmer antisense oligonucleotide (ASO) candidates have been designed at Eisai Co. Ltd. to reduce microtubule-associated ...

This current administration is like nothing that we've seen before,” said a managing partner of a global venture capital firm ...

Curently the only available blood test to tell which women are at risk of postpartum depression (PPD) is the one that ...

Europe has more oncology startups than the U.S., but many more U.S. companies scale up to the later growth stage. Given the ...